Completed
Phase III Study of AZT with Two Dose Levels of Intron-A in Treatment of AIDS-Related Kaposi's Sarcoma
Learn MoreCompleted
A Prospective, Randomized Comparative Trial of Combination Chemotherapy of MAC Infection in AIDS: Trial results
Learn MoreCompleted
Renal monitoring in people living with HIV
Learn MoreCompleted
Clindamycin, Primaquine vs.Trimethoprim Sulphamethoxazole
Learn MoreCompleted
A case-control study of novel bone imaging techniques and plasma markers in HIV-infected persons with or without fragility fractures
Learn MoreCompleted
Non-alcoholic fatty liver disease (NAFLD) in HIV: The role of nutritional interventions
Learn MoreCompleted
Predicting Abnormalities in Lactate Production and Clearance Related to Treatment and Liver Disease and Measuring the Impact of Vitamin Supplementation
Learn MoreCompleted
Addition of ezetimibe (Ezetrol®) to ongoing therapy with rosuvastatin (Crestor®) in HIV positive patients not reaching cholesterol targets
Learn More
CTN Trials have been approved by the Community Advisory Committee of the Canadian HIV Trials Network and the Network’s Scientific Review Committee, or other national peer-review panels such as those at the Canadian Institutes of Health Research and the U.S. National Institutes of Health. CTNPT studies are small-scale investigations designed to determine the feasibility of research concepts, and do not all go through the regular CTN clinical trial review process. For information on the benefits and risks of participating in HIV clinical trials, call CATIE toll-free at 1-800-263-1638.
